Proteonomix Retains Gilford Securities
(firmenpresse) - MOUNTAINSIDE, NJ -- (Marketwire) -- 08/02/11 -- PROTEONOMIX, INC. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to announce that they have engaged the services of for the purposes of assisting and advising the Company on enhancing shareholder value and perform investment banking services for Proteonomix.
Proteonomix's CEO, Michael Cohen, stated, "We are excited to solidify this relationship with Gilford Securities. We anticipate that this relationship will assist us in bringing our Proteoderm anti-aging skin care line to market, as well as facilitate for our StromaCel cardiovascular disease therapy and our UMK-121 liver treatment."
"I would also like to take this time to thank our shareholders of the Company. Today marks the beginning of a new chapter in Proteonomix history," Mr. Cohen also said.
About Proteonomix, Inc.: Proteonomix is a biotechnology company focused on developing therapeutics based upon use of human cells and their derivatives. The Proteonomix Family of companies includes Proteoderm, StromaCel, National Stem Cell, PRTMI, The Sperm Bank of New York and THOR BioPharma. Proteoderm, Inc. is wholly owned subsidiary that has developed an anti-aging line of skin care products. StromaCel, Inc. develops therapeutic modalities for treatment of Cardiovascular Disease (CVD). National Stem Cell, Inc. is Proteonomix's subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI") intends to focus on translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. , , and .
About Gilford Securities, Inc: Founded in 1979 by Gilford Securities is a full-service boutique investment firm providing an array of financial services to institutional and retail clients. From award-winning corporate finance services and equity research to retirement planning and wealth management, our financial experts are prepared to accommodate the needs of all investors.
Forward-looking statements: Certain statements contained herein are "forward-looking statements" (as defined- Private Securities Litigation Reform Act 1995). Proteonomix, Inc. cautions that statements made in press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. Forward-looking statements are based on estimates and opinions of management at time statements are made.
Contact:
Proteonomix, Inc.
Michael Cohen
Phone: +1-973-544-6116
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.08.2011 - 19:10 Uhr
Sprache: Deutsch
News-ID 41017
Anzahl Zeichen: 0
contact information:
Town:
MOUNTAINSIDE, NJ
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 194 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Proteonomix Retains Gilford Securities"
steht unter der journalistisch-redaktionellen Verantwortung von
Proteonomix (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
